DMD Simcyp

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cresteil, T.
Right arrow Articles by Gueritte, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cresteil, T.
Right arrow Articles by Gueritte, F.

Vol. 30, Issue 4, 438-445, April 2002

Regioselective Metabolism of Taxoids by Human CYP3A4 and 2C8: Structure-Activity Relationship

Thierry Cresteil, Bernard Monsarrat, Joelle Dubois, Michelle Sonnier, Paul Alvinerie, and Françoise Gueritte

Centre National de la Recherche Scientifique Unité Mixte Recherche 8532, Villejuif, France (T.C., M.S.); Institut de Pharmacologie et de Biologie Structurale, Centre National de la Recherche Scientifique Unité Mixte Recherche 5089, Toulouse, France (B.M., P.A.); Institut de Chimie des Substances Naturelles, Centre National de la Recherche Scientifique Unité Propre de Recherche 2301, Gif sur Yvette, France (J.D., F.G.)

Paclitaxel and docetaxel are metabolized by liver microsomal monooxygenases into inactive metabolites further eliminated from the body via the bile route. In spite of their close chemical structure, the two drugs are oxidized by two different enzymes; CYP2C8 catalyzes the 6-hydroxylation on the taxane ring of paclitaxel, whereas CYP3A4 oxidizes docetaxel on the tert-butyl group of the lateral chain in C13. Since paclitaxel and docetaxel differ only by two substitutions, the role of individual modifications was investigated; the regioselectivity of hydroxylation was assessed by high-pressure liquid chromatography/mass spectrometry, and enzymes implicated in individual reactions were identified using human liver microsomes and recombinant P450 expressed in Ad293 cells. The biotransformation of docetaxel, 10-deacetylpaclitaxel, and 10-deacetylbaccatin III was steadily increased (2- to 5-fold) by the addition of an acetyl group in position 10, suggesting that the presence of a hydrophobic group in position 10 stimulated hydroxylation by P450 proteins. The absence of the lateral chain at C13 in baccatin III severely impaired the metabolism supported by CYP3A4. The presence of a tert-butyl group in the lateral chain of docetaxel favored the hydroxylation on the tert-butyl by CYP3A4, whereas the presence of a phenyl group in the lateral chain facilitated the oxidation on the taxane ring by CYP2C8. Collectively, these data strongly suggested that the structure of the lateral chain and the nature of substituent in position 10 play an important role in determining the regioselective oxidation by P450 proteins and modulate the reaction rate by human liver microsomes.

Copyright © 2002 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 Drug Metab. Dispos.Home page
L.-L. Wang, Y. Li, and S.-F. Zhou
A Bioinformatics Approach for the Phenotype Prediction of Nonsynonymous Single Nucleotide Polymorphisms in Human Cytochromes P450
Drug Metab. Dispos., May 1, 2009; 37(5): 977 - 991.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
V. T. Ly, J. Caceres-Cortes, D. Zhang, W. G. Humphreys, I. V. Ekhato, D. Everett, and S. N. Comezoglu
Metabolism and Excretion of an Oral Taxane Analog, [14C]3'-tert-Butyl-3'-N-tert-butyloxycarbonyl-4-deacetyl-3'-dephenyl-3'-N-debenzoyl-4-O-methoxy-paclitaxel (BMS-275183), in Rats and Dogs
Drug Metab. Dispos., May 1, 2009; 37(5): 1115 - 1128.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
D. Zhang, V. T. Ly, M. Lago, Y. Tian, J. Gan, W. G. Humphreys, and S. N. Comezoglu
CYP3A4-Mediated Ester Cleavage as the Major Metabolic Pathway of the Oral Taxane 3'-tert-Butyl-3'-N-tert-butyloxycarbonyl-4-deacetyl-3'-dephenyl-3'-N-debenzoyl-4-O-methoxycarbonyl-paclitaxel (BMS-275183)
Drug Metab. Dispos., April 1, 2009; 37(4): 710 - 718.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. Goel, M. Cohen, S. N. Comezoglu, L. Perrin, F. Andre, D. Jayabalan, L. Iacono, A. Comprelli, V. T. Ly, D. Zhang, et al.
The Effect of Ketoconazole on the Pharmacokinetics and Pharmacodynamics of Ixabepilone: A First in Class Epothilone B Analogue in Late-Phase Clinical Development
Clin. Cancer Res., May 1, 2008; 14(9): 2701 - 2709.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
J.-W. Zhang, G.-B. Ge, Y. Liu, L.-M. Wang, X.-B. Liu, Y.-Y. Zhang, W. Li, Y.-Q. He, Z.-T. Wang, J. Sun, et al.
Taxane's Substituents at C3' Affect Its Regioselective Metabolism: Different in Vitro Metabolism of Cephalomannine and Paclitaxel
Drug Metab. Dispos., February 1, 2008; 36(2): 418 - 426.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Y. Chen, Y. Tang, M.-T. Wang, S. Zeng, and D. Nie
Human Pregnane X Receptor and Resistance to Chemotherapy in Prostate Cancer
Cancer Res., November 1, 2007; 67(21): 10361 - 10367.
[Abstract] [Full Text] [PDF]

Home page
 J AndrolHome page
R. Obligacion, M. Murray, and I. Ramzan
Drug-Metabolizing Enzymes and Transporters: Expression in the Human Prostate and Roles in Prostate Drug Disposition
J Androl, March 1, 2006; 27(2): 138 - 150.
[Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
B. J. Komoroski, R. A. Parise, M. J. Egorin, S. C. Strom, and R. Venkataramanan
Effect of the St. John's Wort Constituent Hyperforin on Docetaxel Metabolism by Human Hepatocyte Cultures
Clin. Cancer Res., October 1, 2005; 11(19): 6972 - 6979.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. Mani, H. Huang, S. Sundarababu, W. Liu, G. Kalpana, A. B. Smith, and S. B. Horwitz
Activation of the Steroid and Xenobiotic Receptor (Human Pregnane X Receptor) by Nontaxane Microtubule-Stabilizing Agents
Clin. Cancer Res., September 1, 2005; 11(17): 6359 - 6369.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
H. Hichiya, T. Tanaka-Kagawa, A. Soyama, H. Jinno, S. Koyano, N. Katori, E. Matsushima, S. Uchiyama, H. Tokunaga, H. Kimura, et al.
FUNCTIONAL CHARACTERIZATION OF FIVE NOVEL CYP2C8 VARIANTS, G171S, R186X, R186G, K247R, AND K383N, FOUND IN A JAPANESE POPULATION
Drug Metab. Dispos., May 1, 2005; 33(5): 630 - 636.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
L. Quintieri, C. Geroni, M. Fantin, R. Battaglia, A. Rosato, W. Speed, P. Zanovello, and M. Floreani
Formation and Antitumor Activity of PNU-159682, A Major Metabolite of Nemorubicin in Human Liver Microsomes
Clin. Cancer Res., February 15, 2005; 11(4): 1608 - 1617.
[Abstract] [Full Text] [PDF]

Home page
 J Clin PharmacolHome page
R. L. Walsky, E. A. Gaman, and R. S. Obach
Examination of 209 Drugs for Inhibition of Cytochrome P450 2C8
J. Clin. Pharmacol., January 1, 2005; 45(1): 68 - 78.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
T. M. Polasek, D. J. Elliot, B. C. Lewis, and J. O. Miners
Mechanism-Based Inactivation of Human Cytochrome P4502C8 by Drugs in Vitro
J. Pharmacol. Exp. Ther., December 1, 2004; 311(3): 996 - 1007.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
G. A. Schoch, J. K. Yano, M. R. Wester, K. J. Griffin, C. D. Stout, and E. F. Johnson
Structure of Human Microsomal Cytochrome P450 2C8: EVIDENCE FOR A PERIPHERAL FATTY ACID BINDING SITE
J. Biol. Chem., March 5, 2004; 279(10): 9497 - 9503.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2002 by the American Society for Pharmacology and Experimental Therapeutics.